Impact GLP-1 Agonists Following Bariatric
Condition(s):Morbid Obesity; Metabolic Syndrome; Diabetes Mellitus; Hypertension; Obstructive Sleep Apnea of AdultLast Updated:January 31, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Morbid Obesity; Metabolic Syndrome; Diabetes Mellitus; Hypertension; Obstructive Sleep Apnea of AdultLast Updated:January 31, 2024Not yet recruiting
Condition(s):Delayed Gastric Emptying; GastroparesisLast Updated:December 5, 2023Recruiting
Condition(s):Type II DiabetesLast Updated:February 20, 2024Completed
Condition(s):Gastric Ultrasound; Glucagon-like Peptide 1; Point of Care UltrasoundLast Updated:September 18, 2023Recruiting
Condition(s):Diabetes; Gastric Content Aspiration; Glucagon-like Peptide 1; GLP-1Last Updated:August 21, 2023Recruiting
Condition(s):ObesityLast Updated:January 30, 2023Recruiting
Condition(s):Diabetes Mellitus, Type 2Last Updated:March 18, 2024Recruiting
Condition(s):Cystic Fibrosis; Pancreatic Insufficiency; Abnormal Glucose Tolerance; DiabetesLast Updated:February 29, 2024Recruiting
Condition(s):Panhypopituitarism; Craniopharyngioma; Hypothalamic ObesityLast Updated:January 23, 2024Recruiting
Condition(s):Alcohol Use DisorderLast Updated:February 9, 2022Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.